Lucilla
Lucilla Brattico, Ornago IT
Patent application number | Description | Published |
---|---|---|
20100059829 | PROCESS FOR MANUFACTURING A MEMORY DEVICE INCLUDING A VERTICAL BIPOLAR JUNCTION TRANSISTOR AND A CMOS TRANSISTOR WITH SPACERS - A bipolar selection transistor and a circuitry MOS transistor for a memory device are formed in a semiconductor body. The bipolar selection transistor is formed by implanting a buried collector, implanting a base region on the buried collector, forming a silicide protection mask on the semiconductor body, and implanting an emitter region and a control contact region. The circuitry MOS transistor is formed by defining a gate on the semiconductor body, forming lateral spacers on the sides of the gate and implanting source and drain regions on the sides of the lateral spacers. Then, a silicide region is formed on the emitter, base contact, source and drain regions and the gate, in a self-aligned way. The lateral spacers are multilayer structures including at least two different layers, one of which is used to form the silicide protection mask on the bipolar selection transistor. Thereby, the dimensions of the lateral spacers are decoupled from the thickness of the silicide protection mask. | 03-11-2010 |
Lucilla D'Adamo, Verona IT
Patent application number | Description | Published |
---|---|---|
20090192194 | Cyclic Amine Derivatives, Processes For Their Preparation, And Pharmaceutical Compositions Containing Them - A compound of formula (I) | 07-30-2009 |
20100286152 | N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR - The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof, | 11-11-2010 |
Lucilla Madamba, Toronto CA
Patent application number | Description | Published |
---|---|---|
20130086480 | CALENDAR APPLICATION VIEWS IN PORTRAIT DUAL MODE - A communication device comprising a microprocessor readable computer readable medium is provided that includes microprocessor executable instructions to provide graphical output, in a first mode, simultaneously on multiple screens and, in a second mode, simultaneously as multiple displays on a common screen. | 04-04-2013 |
20130113835 | CALENDAR APPLICATION VIEWS IN LANDSCAPE DUAL MODE - A communication device comprising a microprocessor readable computer readable medium is provided that includes microprocessor executable instructions to alter displayed information based on screen orientation. | 05-09-2013 |
Lucilla Parnetti, Perugia IT
Patent application number | Description | Published |
---|---|---|
20130183278 | METHOD FOR DIAGNOSIS - The present invention relates to method of identifying whether or not an individual has Parkinson's disease (PD). In particular, the invention relates to a method for identifying whether or not an individual has PD as opposed to another neurodegenerative disease. The method of the invention comprises measuring the concentration of α-synuclein (α-syn) and the concentration of unphosphorylated tau (tau) and/or phosphorylated tau (p-tau) in a cerebrospinal fluid sample taken from an individual. The method also comprises calculating the ratio of the concentration of tau and/or p-tau to the concentration of α-syn, and thereby determining whether or not the individual has PD. | 07-18-2013 |
Lucilla Steinaa, Horsholm DK
Patent application number | Description | Published |
---|---|---|
20080253993 | Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating Epitope - Disclosed is a method for inducing an immune response against autologous Epidermal Growth Factor Receptor (EGFR) in humans. The method comprises effecting uptake by antigen presenting cells of epitopes (preferably all) from the extracellular portion of human EGFR and of at least one non-human T helper epitope (T | 10-16-2008 |
20100040606 | Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections - Disclosed are novel polyclonal antibodies, which target respiratory syncyticilal virus (RSV), and novel high affinity antibody molecules reactive with RSV. The polyclonal antibodies may comprise antibody molecules which are reactive with both RSV protein F and RSV protein G, and preferably the polyclonal antibodies target a variety of epitopes on these proteins. The single antibody molecules of the invention are shown to exhibit affinities which provide for dissociation constants as low as in the picomolar range. Also disclosed are methods of producing the antibodies of the invention as well as methods of their use in treatment for RSV infection. | 02-18-2010 |
20110158984 | ANTI-ORTHOPOXVIRUS RECOMBINANT POLYCLONAL ANTIBODY - Disclosed is an anti-orthopoxvirus recombinant polyclonal antibody comprising distinct members which in union are capable of binding at least three orthopoxvirus related antigens, a pharmaceutical composition comprising the antibody, and a method for its production. Also disclosed is a polyclonal cell line capable of producing the recombinant polyclonal antibody as therapeutic methods utilizing the polyclonal antibody. Finally, the invention also pertains to a method for screening for useful V | 06-30-2011 |
Lucilla Steinaa, Hoersholm DK
Patent application number | Description | Published |
---|---|---|
20090004192 | Recombinant anti-epidermal growth factor receptor antibody compositions - The invention relates to the field of recombinant antibodies for use in human cancer therapy. More specifically the invention provides compositions or mixtures of antibodies capable of binding human EGFR. Antibody compositions with 3 or more antibodies shown synergy in reduction of proliferation of representative cancer cell lines. Advantageous results have also been obtained with a composition comprising two different chimeric anti-hEGFR antibodies which show a new mechanism of action based on rapid and efficient receptor internalisation, induction of terminal differentiation and subsequent tumour eradication in an animal model. The antibodies of the invention can be manufactured in one bioreactor as a polyclonal antibody. | 01-01-2009 |
20110129855 | Recombinant Anti-Epidermal Growth Factor Receptor Antibody Compositions - The invention relates to the field of recombinant antibodies for use in human cancer therapy. More specifically the invention provides compositions or mixtures of antibodies capable of binding human EGFR. Antibody compositions with 3 or more antibodies shown synergy in reduction of proliferation of representative cancer cell lines. Advantageous results have also been obtained with a composition comprising two different chimeric anti-hEGFR antibodies which show a new mechanism of action based on rapid and efficient receptor internalisation, induction of terminal differentiation and subsequent tumour eradication in an animal model. The antibodies of the invention can be manufactured in one bioreactor as a polyclonal antibody. | 06-02-2011 |
20110135636 | Recombinant Anti-Epidermal Growth Factor Receptor Antibody Compositions - The invention relates to the field of recombinant antibodies for use in human cancer therapy. More specifically the invention provides compositions or mixtures of antibodies capable of binding human EGFR. Antibody compositions with 3 or more antibodies shown synergy in reduction of proliferation of representative cancer cell lines. Advantageous results have also been obtained with a composition comprising two different chimeric anti-hEGFR antibodies which show a new mechanism of action based on rapid and efficient receptor internalisation, induction of terminal differentiation and subsequent tumour eradication in an animal model. The antibodies of the invention can be manufactured in one bioreactor as a polyclonal antibody. | 06-09-2011 |